Subcutaneous infliximab as a maintenance option in pediatric IBD: a real-world cohort including younger and lower-weight children
{{output}}
Background: Subcutaneous infliximab (SC-IFX) offers an alternative to intravenous infliximab (IV-IFX) in adults with inflammatory bowel disease (IBD), but evidence in children is scarce. This study reports treatment persistence, ... ...
